ERBB2 and breast cancer: Examples of comparative oncology utility in canine mammary tumors research include the use of immunohistochemical subtyping based on HER2, ER, and PR status paralleled with classifications in human breast cancer; these findings suggest promising avenues in diagnostics and prognostic assessment for canines [18].